Title:
BIOMARKERS AND METHODS FOR DIAGNOSIS OF EARLY STAGE PANCREATIC DUCTAL ADENOCARCINOMA
Document Type and Number:
WIPO Patent Application WO/2015/171736
Kind Code:
A3
Abstract:
The present invention provides biomarker compositions and methods for the diagnosis and prognosis of PDAC. In a particular embodiment, the invention provides methods and compositions for screening, diagnosis and prognosis of early stage, asymptomatic PDAC.
Inventors:
MULVIHILL SEAN J (US)
FIRPO MATTHEW A (US)
FIRPO MATTHEW A (US)
Application Number:
PCT/US2015/029429
Publication Date:
April 07, 2016
Filing Date:
May 06, 2015
Export Citation:
Assignee:
UNIV UTAH RES FOUND (US)
International Classes:
C12Q1/68; C40B30/04; G01N33/50
Domestic Patent References:
| WO2013126539A1 | 2013-08-29 |
Foreign References:
| US20100092476A1 | 2010-04-15 | |||
| US20130323734A1 | 2013-12-05 |
Other References:
HONG ET AL.: "ALCAM Is Associated With Chemoresistance and Tumor Cell Adhesion in Pancreatic Cancer.", JOURNAL OF SURGICAL ONCOLOGY, vol. 101, no. 7, 1 June 2010 (2010-06-01), pages 564 - 569, XP055360403
See also references of EP 3140426A4
See also references of EP 3140426A4
Attorney, Agent or Firm:
SPAIN, Astrid, R. et al. (222 East 41st StreetNew York, NY, US)
Download PDF:
Previous Patent: METHOD AND SYSTEM FOR FORMING SITE NETWORK
Next Patent: NEUTRON AND GAMMA SENSITIVE FIBER SCINTILLATORS
Next Patent: NEUTRON AND GAMMA SENSITIVE FIBER SCINTILLATORS